Livot-AM Tablet

Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg Tablets

Livot-AM Tablet — Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg
Dosage Form Tablet
Pack Type Alu-Alu Blister
Pack Size 10 x 10 Tablets
MRP ₹ 1450
Therapy Pulmonology / G.P. — LTRA + Antihistamine + Mucolytic
Storage Store below 30 °C in a dry place, protected from light and moisture.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Livot-AM Tablet

Livot-AM Tablet combines Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg — triple-action for allergic cough with thick mucus. Montelukast targets leukotriene-driven inflammation, Levocetirizine blocks H1 receptors, Ambroxol thins mucus for easier expectoration.

Manufactured by Trumac Healthcare under WHO-GMP. Available for monopoly-based PCD pharma franchise and third-party manufacturing.

Indications

  • Allergic cough with productive sputum
  • Allergic bronchitis
  • Asthma with thick mucus
  • Post-viral cough with congestion

Mechanism of Action

Levocetirizine is the active R-enantiomer of cetirizine — a selective second-generation H1 antihistamine. Higher H1 receptor affinity than cetirizine with lower brain penetration — minimal sedation. Onset 30 minutes, duration 24 hours. Montelukast is a leukotriene receptor (CysLT1) antagonist — blocks effects of leukotrienes D4 produced from mast cells and eosinophils. Reduces bronchoconstriction, mucus hypersecretion and oedema characteristic of allergic asthma and rhinitis. Ambroxol stimulates surfactant production and reduces mucus viscosity by depolymerising mucopolysaccharide fibres — facilitating expectoration.

Dosage & Administration

Adults: 1 tablet once daily in evening.

Side Effects

Headache, GI upset, rash. Rare neuropsychiatric symptoms (Montelukast).

Contraindications & Precautions

Hypersensitivity, severe hepatic impairment, history of mood disorders.

Storage

Store below 30 °C in a dry place, protected from light and moisture.

PCD Pharma Franchise & Third-Party Manufacturing
Livot-AM Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Livot-AM Tablet used for?

Livot-AM Tablet contains Montelukast 10 mg + Levocetirizine 5 mg + Ambroxol 75 mg. Used as per the indications described above.

How should Livot-AM Tablet be taken?

As directed by your physician. Complete the prescribed course.

Is Livot-AM Tablet available for PCD pharma franchise?

Yes, Trumac Healthcare offers Livot-AM Tablet on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Livot-AM Tablet be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Livot-AM Tablet WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.